Uzbekstan

Dr. Reddy’s entered Uzbekistan in 1994 through a joint venture. Our representation office was opened in Tashkent in 2005. The first products to be registered in Uzbekistan were Ciprolet and Ibuklin. Today, around 11 brands of Dr. Reddy’s are being sold in the Uzbek market. We have partnership with 7 key national distributors who cover 70% Uzbek pharma market.

Key highlights

• Largest and most respected Indian company in Uzbekistan
• Ranked 18th among all pharma companies (according to Pharmexpert data).
• Our Brands: Enam and Ciprolet are leaders in the respective TAs.

Key Therapeutic Areas:

• Anti-Infective
• Cardiology
• Gastroenterology
• Pain Management